US Tizanidine Market demand is influenced by the availability of generic tablets and capsules through retail and hospital pharmacies. These formulations provide established oral treatment options for eligible patients requiring spasticity management. The Tizanidine Market was valued at US$ 637.89 million in 2025 and is expected to reach US$ 1,068.05 million by 2034, registering a CAGR of 5.89%...